
Ad Campaign for Weight-Loss Drugs Reinforces Proper Use
Eli Lilly and Company has launched a direct-to-consumer advertising campaign for their obesity and type 2 diabetes drug, tirzepatide, urging people not to use anti-obesity medications outside of FDA indications. The campaign, including an ad called “Big Night,” aims to address the misuse of these drugs for cosmetic weight loss rather than their intended purpose….